A detailed history of Sachetta, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sachetta, LLC holds 49 shares of GH stock, worth $1,392. This represents 0.0% of its overall portfolio holdings.

Number of Shares
49
Previous 49 -0.0%
Holding current value
$1,392
Previous $1.33 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$21.58 - $29.5 $1,057 - $1,445
49 New
49 $1.33 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.9B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Sachetta, LLC Portfolio

Follow Sachetta, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sachetta, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sachetta, LLC with notifications on news.